The impact of type 1a endoleak on the long-term outcome after EVAR

OBJECTIVE: Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACTA CHIRURGICA BELGICA 2021-09, Vol.121 (5), p.333-339
Hauptverfasser: Van Slambrouck, Jan, Mufty, Hozan, Maleux, Geert, Houthoofd, Sabrina, Devooght, Anne, Slots, Charlotte, Daenens, Kim, Fourneau, Inge
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 339
container_issue 5
container_start_page 333
container_title ACTA CHIRURGICA BELGICA
container_volume 121
creator Van Slambrouck, Jan
Mufty, Hozan
Maleux, Geert
Houthoofd, Sabrina
Devooght, Anne
Slots, Charlotte
Daenens, Kim
Fourneau, Inge
description OBJECTIVE: Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follow-up. METHODS: All patients treated with EVAR between February 2001 and August 2017 in our institution were included. Data were collected retrospectively. A descriptive analysis of subgroups with type 1a endoleak at case end or with type 1a endoleak first encountered during follow-up was performed. RESULTS: In total, 468 patients were included for analysis. At the case end of the EVAR procedure, in 5.3% (25/468) of patients, a type 1a endoleak was seen. In 72% of cases (18/25) the type 1a endoleak spontaneously disappeared on the first follow-up computed tomography angiography and never recurred. At the end of the follow-up period, no patient in this subgroup died with a type 1a endoleak on follow-up. In 3.4% (16/468) of all cases, a type 1a endoleak was encountered for the first time during follow-up. In 87.5% (14/16) of these cases, reintervention was performed. Two patients died with a persisting type 1a endoleak during follow-up. CONCLUSIONS: Clinicians should differentiate between the type 1a endoleak at the case end and the type 1a endoleak first occurring during follow-up. For type 1a endoleak at the case end, expectant management can be adopted. Delayed type 1a endoleak seen during follow-up rarely seals spontaneously and needs reintervention in the majority of cases.
format Article
fullrecord <record><control><sourceid>kuleuven_FZOIL</sourceid><recordid>TN_cdi_kuleuven_dspace_123456789_658167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>123456789_658167</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_123456789_6581673</originalsourceid><addsrcrecordid>eNqNjL0OgjAYADtoIkHe4dscDEkLLcVRDcbZENemgQ9_gJZIMfr2dvABmC6XXG5BAkopiwUX-YpE4_j0SjlNuJQBOZR3hEc_6MqBbcB9BwSmAU1tO9QtWAPOF501t9jhqwc7ucr2CLrxCsV1f1mTZaO7EaM_Q7I5FeXxHLdTh9MbjapH_0fFkpSLTOY7lYmcZTINyXZeqdzHpfO_P0ncRxI</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The impact of type 1a endoleak on the long-term outcome after EVAR</title><source>Lirias (KU Leuven Association)</source><creator>Van Slambrouck, Jan ; Mufty, Hozan ; Maleux, Geert ; Houthoofd, Sabrina ; Devooght, Anne ; Slots, Charlotte ; Daenens, Kim ; Fourneau, Inge</creator><creatorcontrib>Van Slambrouck, Jan ; Mufty, Hozan ; Maleux, Geert ; Houthoofd, Sabrina ; Devooght, Anne ; Slots, Charlotte ; Daenens, Kim ; Fourneau, Inge</creatorcontrib><description>OBJECTIVE: Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follow-up. METHODS: All patients treated with EVAR between February 2001 and August 2017 in our institution were included. Data were collected retrospectively. A descriptive analysis of subgroups with type 1a endoleak at case end or with type 1a endoleak first encountered during follow-up was performed. RESULTS: In total, 468 patients were included for analysis. At the case end of the EVAR procedure, in 5.3% (25/468) of patients, a type 1a endoleak was seen. In 72% of cases (18/25) the type 1a endoleak spontaneously disappeared on the first follow-up computed tomography angiography and never recurred. At the end of the follow-up period, no patient in this subgroup died with a type 1a endoleak on follow-up. In 3.4% (16/468) of all cases, a type 1a endoleak was encountered for the first time during follow-up. In 87.5% (14/16) of these cases, reintervention was performed. Two patients died with a persisting type 1a endoleak during follow-up. CONCLUSIONS: Clinicians should differentiate between the type 1a endoleak at the case end and the type 1a endoleak first occurring during follow-up. For type 1a endoleak at the case end, expectant management can be adopted. Delayed type 1a endoleak seen during follow-up rarely seals spontaneously and needs reintervention in the majority of cases.</description><identifier>ISSN: 0001-5458</identifier><language>eng</language><publisher>TAYLOR &amp; FRANCIS LTD</publisher><ispartof>ACTA CHIRURGICA BELGICA, 2021-09, Vol.121 (5), p.333-339</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,780,27860</link.rule.ids><linktorsrc>$$Uhttps://lirias.kuleuven.be/handle/123456789/658167$$EView_record_in_KU_Leuven_Association$$FView_record_in_$$GKU_Leuven_Association$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Van Slambrouck, Jan</creatorcontrib><creatorcontrib>Mufty, Hozan</creatorcontrib><creatorcontrib>Maleux, Geert</creatorcontrib><creatorcontrib>Houthoofd, Sabrina</creatorcontrib><creatorcontrib>Devooght, Anne</creatorcontrib><creatorcontrib>Slots, Charlotte</creatorcontrib><creatorcontrib>Daenens, Kim</creatorcontrib><creatorcontrib>Fourneau, Inge</creatorcontrib><title>The impact of type 1a endoleak on the long-term outcome after EVAR</title><title>ACTA CHIRURGICA BELGICA</title><description>OBJECTIVE: Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follow-up. METHODS: All patients treated with EVAR between February 2001 and August 2017 in our institution were included. Data were collected retrospectively. A descriptive analysis of subgroups with type 1a endoleak at case end or with type 1a endoleak first encountered during follow-up was performed. RESULTS: In total, 468 patients were included for analysis. At the case end of the EVAR procedure, in 5.3% (25/468) of patients, a type 1a endoleak was seen. In 72% of cases (18/25) the type 1a endoleak spontaneously disappeared on the first follow-up computed tomography angiography and never recurred. At the end of the follow-up period, no patient in this subgroup died with a type 1a endoleak on follow-up. In 3.4% (16/468) of all cases, a type 1a endoleak was encountered for the first time during follow-up. In 87.5% (14/16) of these cases, reintervention was performed. Two patients died with a persisting type 1a endoleak during follow-up. CONCLUSIONS: Clinicians should differentiate between the type 1a endoleak at the case end and the type 1a endoleak first occurring during follow-up. For type 1a endoleak at the case end, expectant management can be adopted. Delayed type 1a endoleak seen during follow-up rarely seals spontaneously and needs reintervention in the majority of cases.</description><issn>0001-5458</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqNjL0OgjAYADtoIkHe4dscDEkLLcVRDcbZENemgQ9_gJZIMfr2dvABmC6XXG5BAkopiwUX-YpE4_j0SjlNuJQBOZR3hEc_6MqBbcB9BwSmAU1tO9QtWAPOF501t9jhqwc7ucr2CLrxCsV1f1mTZaO7EaM_Q7I5FeXxHLdTh9MbjapH_0fFkpSLTOY7lYmcZTINyXZeqdzHpfO_P0ncRxI</recordid><startdate>20210903</startdate><enddate>20210903</enddate><creator>Van Slambrouck, Jan</creator><creator>Mufty, Hozan</creator><creator>Maleux, Geert</creator><creator>Houthoofd, Sabrina</creator><creator>Devooght, Anne</creator><creator>Slots, Charlotte</creator><creator>Daenens, Kim</creator><creator>Fourneau, Inge</creator><general>TAYLOR &amp; FRANCIS LTD</general><scope>FZOIL</scope></search><sort><creationdate>20210903</creationdate><title>The impact of type 1a endoleak on the long-term outcome after EVAR</title><author>Van Slambrouck, Jan ; Mufty, Hozan ; Maleux, Geert ; Houthoofd, Sabrina ; Devooght, Anne ; Slots, Charlotte ; Daenens, Kim ; Fourneau, Inge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_123456789_6581673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Slambrouck, Jan</creatorcontrib><creatorcontrib>Mufty, Hozan</creatorcontrib><creatorcontrib>Maleux, Geert</creatorcontrib><creatorcontrib>Houthoofd, Sabrina</creatorcontrib><creatorcontrib>Devooght, Anne</creatorcontrib><creatorcontrib>Slots, Charlotte</creatorcontrib><creatorcontrib>Daenens, Kim</creatorcontrib><creatorcontrib>Fourneau, Inge</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>ACTA CHIRURGICA BELGICA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Van Slambrouck, Jan</au><au>Mufty, Hozan</au><au>Maleux, Geert</au><au>Houthoofd, Sabrina</au><au>Devooght, Anne</au><au>Slots, Charlotte</au><au>Daenens, Kim</au><au>Fourneau, Inge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of type 1a endoleak on the long-term outcome after EVAR</atitle><jtitle>ACTA CHIRURGICA BELGICA</jtitle><date>2021-09-03</date><risdate>2021</risdate><volume>121</volume><issue>5</issue><spage>333</spage><epage>339</epage><pages>333-339</pages><issn>0001-5458</issn><abstract>OBJECTIVE: Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follow-up. METHODS: All patients treated with EVAR between February 2001 and August 2017 in our institution were included. Data were collected retrospectively. A descriptive analysis of subgroups with type 1a endoleak at case end or with type 1a endoleak first encountered during follow-up was performed. RESULTS: In total, 468 patients were included for analysis. At the case end of the EVAR procedure, in 5.3% (25/468) of patients, a type 1a endoleak was seen. In 72% of cases (18/25) the type 1a endoleak spontaneously disappeared on the first follow-up computed tomography angiography and never recurred. At the end of the follow-up period, no patient in this subgroup died with a type 1a endoleak on follow-up. In 3.4% (16/468) of all cases, a type 1a endoleak was encountered for the first time during follow-up. In 87.5% (14/16) of these cases, reintervention was performed. Two patients died with a persisting type 1a endoleak during follow-up. CONCLUSIONS: Clinicians should differentiate between the type 1a endoleak at the case end and the type 1a endoleak first occurring during follow-up. For type 1a endoleak at the case end, expectant management can be adopted. Delayed type 1a endoleak seen during follow-up rarely seals spontaneously and needs reintervention in the majority of cases.</abstract><pub>TAYLOR &amp; FRANCIS LTD</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0001-5458
ispartof ACTA CHIRURGICA BELGICA, 2021-09, Vol.121 (5), p.333-339
issn 0001-5458
language eng
recordid cdi_kuleuven_dspace_123456789_658167
source Lirias (KU Leuven Association)
title The impact of type 1a endoleak on the long-term outcome after EVAR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A15%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven_FZOIL&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20type%201a%20endoleak%20on%20the%20long-term%20outcome%20after%20EVAR&rft.jtitle=ACTA%20CHIRURGICA%20BELGICA&rft.au=Van%20Slambrouck,%20Jan&rft.date=2021-09-03&rft.volume=121&rft.issue=5&rft.spage=333&rft.epage=339&rft.pages=333-339&rft.issn=0001-5458&rft_id=info:doi/&rft_dat=%3Ckuleuven_FZOIL%3E123456789_658167%3C/kuleuven_FZOIL%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true